European Network of AI Excellence Centres
Reperio is a MedTech start-up developing innovative diagnostic tests using eye movement with a promise to make healthcare for patients around the world more inclusive and affordable. Last year Reperio received ELISE funding to further advance their research!
Immunotherapy has the potential to be a life-saving treatment for some cancer patients, however, medical experts have a hard time selecting patients that will actually benefit from this therapy. Ellogon AI is developing an AI solution able to quantify biomarkers that support in the identification of those patients. This will increase the overall survival and quality of life of patients, and lower the economic burden of immunotherapy. Ellogon AI has received ELISE funding to further their research.
What would the world look like if there were no language barriers? Unbabel is revolutionizing the way humans and technology collaborate in translation. Unbabel’s Language Operations platform and services integrate seamlessly into customer support and marketing workflows, making it easy for brands to grow by building customer trust around the world. Their solution promises to remove language barriers and they got ELISE funding to advance this goal!
The call for application for the Italian National PhD Program - Industry 4.0 is now online. Check out the details and apply by July 29, 2022!
Do you have a news or an upcoming Elise event to share? Let us know!
